Welcome to CDC stacks | Transatlantic Taskforce on Antimicrobial Resistance : progress report - 35134 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Transatlantic Taskforce on Antimicrobial Resistance : progress report
  • Published Date:
    May 2014
  • Language:
Filetype[PDF-1.13 MB]

  • Description:
    Foreword -- Executive summary -- Introduction -- Recommendations -- Key Area I. Appropriate therapeutic use of antimicrobial drugs in medicine -- Key Area II. Prevention of drug resistant infections -- Key Area III. Strategies to improve the pipeline of new antibacterial drugs for use in human medicine -- Conclusions -- Acknowledgement -- Annex A: Abbreviations and acronyms -- Annex B: TATFAR members -- Annex C: Scope and term of reference of TATFAR -- Annex D: The TATFAR recommendations for future collaboration -- Annex E: Timeline of the TATFAR, 2009-2013 -- Annex F: Ongoing activities: joint, EU, and US.

    The Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was created in 2009 with the goal of improving cooperation between the US and the EU in three key areas: appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities, prevention of healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs. TATFAR identified and adopted 17 recommendations for future collaborations between the US and the EU. The implementation of the recommendations has been carried out through increased communication; regular meetings and joint workshops; and exchange of information and approaches, best practises and methods.

    This report summarises the progress and the outcomes of the implementation of the 17 recommendations, as well as the decision about the future of each recommendation. In addition, it also includes one new recommendation.

    Based on the promise shown by our early cooperation, we decided to renew TATFAR in 2013 for another two-year term. In addition, we agreed to transfer the Secretariat from the European Centre for Disease Prevention and Control (ECDC) to the US Centers for Disease Control and Prevention (CDC) for the renewal term. As TATFAR moved into its two-year renewal period, this report reviews the progress that has been made for each recommendation and feedback to determine whether work toward the recommendation should continue in the future. Work on 15 of the original TATFAR recommendations and one new recommendation will continue into 2015, a strong testament to the benefits of the cooperation between the US and EU.


  • Document Type:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: